People

Our Team

AI Therapeutics has progressed its pipeline of novel, computationally-derived and patient-directed therapies using a highly accomplished and experienced team with expertise to execute on all stages of our pipeline from inception through clinical trials.

"AI Therapeutics is at the forefront of transforming how we match drugs to patients for the best response. Our deep learning AI technology gets smarter each time patient data is analyzed, which helps us accurately select patients to treat." - Dr. Tian Xu

Button Text Button Text Button Text

Leadership

Brigette Roberts, M.D.

Acting CEO

Scott B Kozak

Chief Business Development Officer

Peter Young, Ph.D.

Chief Scientific Officer

Keith Fandrick, Ph.D.

Head of CMC and Process Chemistry

Joan Edwards

Head of Quality Assurance

Gus Roman

Chief of Staff

Brad Parry, Ph.D.

Head of AI

Board of Directors

Jonathan Rothberg, Ph.D.

George Rehm

Management

No items found.

Scientific Advisory Board

Lawrence Melvin, Ph.D.

Tian Xu, Ph.D.

Murat Gunel, M.D.

Chair